Mind Medicine (MindMed) Statistics

Total Valuation

MNMD has a market cap or net worth of $519.92 million. The enterprise value is $280.48 million.

Market Cap	519.92M
Enterprise Value	280.48M

Important Dates

The last earnings date was Thursday, November 7, 2024, after market close.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

MNMD has 73.33 million shares outstanding. The number of shares has increased by 54.45% in one year.

Current Share Class	73.33M
Shares Outstanding	73.33M
Shares Change (YoY)	+54.45%
Shares Change (QoQ)	+6.55%
Owned by Insiders (%)	1.01%
Owned by Institutions (%)	41.86%
Float	53.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.34
P/TBV Ratio	2.14
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.00, with a Debt / Equity ratio of 0.09.

Current Ratio	9.00
Quick Ratio	8.88
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-81.73

Financial Efficiency

Return on equity (ROE) is -54.61% and return on invested capital (ROIC) is -29.52%.

Return on Equity (ROE)	-54.61%
Return on Assets (ROA)	-25.38%
Return on Capital (ROIC)	-29.52%
Revenue Per Employee	n/a
Profits Per Employee	-$1.72M
Employee Count	57
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +159.46% in the last 52 weeks. The beta is 2.33, so MNMD's price volatility has been higher than the market average.

Beta (5Y)	2.33
52-Week Price Change	+159.46%
50-Day Moving Average	6.42
200-Day Moving Average	7.45
Relative Strength Index (RSI)	50.85
Average Volume (20 Days)	1,817,772

Short Selling Information

The latest short interest is 9.98 million, so 13.61% of the outstanding shares have been sold short.

Short Interest	9.98M
Short Previous Month	10.21M
Short % of Shares Out	13.61%
Short % of Float	18.62%
Short Ratio (days to cover)	16.07

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-93.66M
Pretax Income	-125.32M
Net Income	-97.80M
EBITDA	n/a
EBIT	-93.66M
Earnings Per Share (EPS)	-$1.64

Full Income Statement

Balance Sheet

The company has $295.28 million in cash and $24.31 million in debt, giving a net cash position of $270.97 million or $3.70 per share.

Cash & Cash Equivalents	295.28M
Total Debt	24.31M
Net Cash	270.97M
Net Cash Per Share	$3.70
Equity (Book Value)	262.19M
Book Value Per Share	3.21
Working Capital	266.09M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-74.34M
Capital Expenditures	n/a
Free Cash Flow	-74.34M
FCF Per Share	-$1.01

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

MNMD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-54.45%
Shareholder Yield	-54.45%
Earnings Yield	-18.82%
FCF Yield	-14.31%

Analyst Forecast

The average price target for MNMD is $28.75, which is 305.50% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$28.75
Price Target Difference	305.50%
Analyst Consensus	Strong Buy
Analyst Count	9
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on August 29, 2022. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Aug 29, 2022
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2